Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Return on Invested Capital (2020 - 2025)

X4 Pharmaceuticals' Return on Invested Capital history spans 6 years, with the latest figure at 0.44% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 12.0% year-over-year to 0.44%; the TTM value through Dec 2025 reached 0.44%, down 12.0%, while the annual FY2025 figure was 0.49%, 12.0% down from the prior year.
  • Return on Invested Capital reached 0.44% in Q4 2025 per XFOR's latest filing, up from 0.92% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.09% in Q1 2025 to a low of 1.43% in Q1 2024.
  • Average Return on Invested Capital over 5 years is 0.78%, with a median of 0.9% recorded in 2025.
  • The largest YoY upside for Return on Invested Capital was 134bps in 2025 against a maximum downside of -104bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.86% in 2021, then fell by -1bps to 0.87% in 2022, then dropped by -8bps to 0.94% in 2023, then skyrocketed by 66bps to 0.32% in 2024, then plummeted by -38bps to 0.44% in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Return on Invested Capital are 0.44% (Q4 2025), 0.92% (Q3 2025), and 1.2% (Q2 2025).